Parkinson's Disease: An Update THURSDAY, May 24, 2018 12:15pm–Hope Conference Center PARKINSON’S DISEASE: DIAGNOSIS AND MANAGEMENT NEAL HERMANOWICZ, MD DIRECTOR, MOVEMENT DISORDERS PROGRAM, UC IRVINE PLANNER/MODERATOR: Michael Marvi, MD, Director, Movement Disorders and Concussion Management Center, Hycy and Howard Hill Neuroscience Institute, PSJMC FACULTY/PLANNER DISCLOSURES: It is our policy to ensure that planners, faculty and content are independent of commercial bias. Dr. Marvi states he has no financial relationships with commercial interests to disclose. Dr. Hermanowicz discloses he is involved with clinical trials, consulting, speakers bureau, and/or employment: with Acadia, Adamas, Allergan, Cynapsus, Eli Lilly, Global Kinetics Corporation, Huntington Study Group, Parkinson Study Group, Pfizer, Teva, UCB, and UCI. It is our policy to review presentations ahead of time in order to resolve any potential conflicts of interest. No conflicts were identified in the review of today’s presentation. Disclosures for members of the Medical Education Committee may be found at the CME sign-in desk and on the CME website at www.providencecme.org. Click Here For Learning Objectives Release Date: 8-7-18 Review Date: 9/21 Termination Date: Providence Saint Joseph Medical Center designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

5/24/2018 Neal Hermanowicz, MD. Presenter Hope Conference Center

Are you sure? If you wish to continue without passing the post test no credit will be given at this time. You may retake the test at any time. Clicking (Yes, I will retest later), clicking (No, I will retest now)